Fig. 1From: Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adultsStudy flowchart. ABC abacavir, 3TC Lamivudine, RPV rilpivirine, EFV efavirenz, PI protease inhibitor, VL viral loadBack to article page